Duchenne's Muscular Dystrophy (DMD) Withdrawn Phase 2 Trials for Prednisone (DB00635)

Also known as: Duchenne's Muscular Dystrophy / Duchenne Muscular Dystrophy (DMD) / Duchenne Muscular Dystrophy / Muscular Dystrophy, Duchenne / Muscular dystrophy

IndicationStatusPhase
DBCOND0066749 (Duchenne's Muscular Dystrophy (DMD))Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02036463A Trial of Chronotherapy of Corticosteroids in Duchenne Muscular DystrophySupportive Care